Published in J Am Coll Cardiol on January 01, 1998
In-stent Restenosis in Patients With Patent Previous Bare Metal Stent | NCT01296399
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart (2003) 1.76
A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol (2008) 1.58
Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol (2011) 1.32
The representative porcine model for human cardiovascular disease. J Biomed Biotechnol (2010) 1.06
Localized ultrasound enhances delivery of rapamycin from microbubbles to prevent smooth muscle proliferation. J Control Release (2011) 0.99
Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells. Hum Mol Genet (2009) 0.97
Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. Eur Heart J (2012) 0.94
Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med (2008) 0.92
Restenosis after percutaneous angioplasty: the role of vascular inflammation. Vasc Health Risk Manag (2005) 0.91
Nanoparticulate carriers for the treatment of coronary restenosis. Int J Nanomedicine (2007) 0.90
Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model. J Korean Med Sci (2007) 0.89
Increased artery wall stress post-stenting leads to greater intimal thickening. Lab Invest (2011) 0.87
Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol (2009) 0.86
First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model. Clin Res Cardiol (2013) 0.86
Inflammation and in-stent restenosis: the role of serum markers and stent characteristics in carotid artery stenting. PLoS One (2011) 0.86
Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: results from the prospective multi-center German Cypher Stent Registry. Clin Res Cardiol (2007) 0.85
Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model. Biomed Res Int (2013) 0.85
Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients. Yonsei Med J (2005) 0.85
Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling. Am J Physiol Heart Circ Physiol (2014) 0.85
Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent. J Zhejiang Univ Sci B (2010) 0.84
Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine. Cardiovasc Res (2009) 0.83
Cutting balloons for the treatment of vascular stenoses. Eur Radiol (2006) 0.82
Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents. Int J Nanomedicine (2014) 0.82
A novel mouse model of in-stent restenosis. Atherosclerosis (2009) 0.81
Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model. Heart (2007) 0.81
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease. Ther Clin Risk Manag (2016) 0.80
Drug-eluting stents ameliorate pulmonary vein stenotic changes in pigs in vivo. Pediatr Cardiol (2010) 0.80
Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol (2012) 0.80
Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model. Clin Res Cardiol (2007) 0.80
A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio. BMC Cardiovasc Disord (2016) 0.79
The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases. J Cell Physiol (2015) 0.79
Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management. Z Kardiol (2005) 0.79
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease. Can J Cardiol (2006) 0.79
Long-term effect of PROLI/NO on cellular proliferation and phenotype after arterial injury. Free Radic Biol Med (2015) 0.79
Two-year clinical outcome after carvedilol-loaded stent implantation in patients with coronary artery disease. Korean J Intern Med (2011) 0.78
Nanotechnology in interventional cardiology. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.78
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits. PLoS One (2015) 0.78
Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis. PLoS One (2014) 0.78
Efficacy of intramuscular methyl prednisolone in preventing restenosis after coronary artery stenting with bare-metal stainless steel stent: a double-blind, randomised, controlled clinical trial. Cardiovasc J Afr (2011) 0.78
Carotid artery stenting using a novel self-expanding braided nickel-titanium stent: feasibility and safety porcine trial. Cardiovasc Intervent Radiol (2009) 0.78
Effects of ramiprilat-coated stents on neointimal hyperplasia, inflammation, and arterial healing in a porcine coronary restenosis model. Korean Circ J (2011) 0.78
Tissue Kallikrein Prevents Restenosis After Stenting of Severe Atherosclerotic Stenosis of the Middle Cerebral Artery: A Randomized Controlled Trial. Medicine (Baltimore) (2016) 0.78
Characterization and in vivo evaluation of a bio-corrodible nitrided iron stent. J Mater Sci Mater Med (2012) 0.77
Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model. Z Kardiol (2005) 0.77
Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery. Int J Nanomedicine (2014) 0.77
Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release. Arq Bras Cardiol (2014) 0.76
Atherogenic Cytokines Regulate VEGF-A-Induced Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells into Endothelial Cells. Stem Cells Int (2015) 0.76
Coronary Injury Score Correlates with Proliferating Cells and Alpha-Smooth Muscle Actin Expression in Stented Porcine Coronary Arteries. PLoS One (2015) 0.76
Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation. J Zhejiang Univ Sci B (2010) 0.76
Vitamin D Supplementation Reduces Intimal Hyperplasia and Restenosis following Coronary Intervention in Atherosclerotic Swine. PLoS One (2016) 0.75
Experimental Pilot Study of a Novel Endobronchial Drug Delivery Catheter. J Bronchology Interv Pulmonol (2015) 0.75
Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model. PLoS One (2015) 0.75
Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries. J Negat Results Biomed (2016) 0.75
Relationship between HLA molecules and late restenosis after coronary stent placement. J Saudi Heart Assoc (2011) 0.75
Evaluating surface bound rTFPI through an in vitro model of vessel wall injury. Thromb Res (2010) 0.75
Plaque morphology detected with Duplex ultrasound before carotid angioplasty and stenting (CAS) is not a predictor of carotid artery in-stent restenosis, a case control study. BMC Neurol (2013) 0.75
3D co-culture model to analyze the crosstalk between endothelial and smooth muscle cells. Tissue Eng Part C Methods (2016) 0.75
A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteries. Cardiovasc Diagn Ther (2015) 0.75
The Effect of Placing Flow-Diverting Stents in Intracranial Collateral Arteries of Miniature Pig. Med Sci Monit (2017) 0.75
Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries. Clin Res Cardiol (2012) 0.75
Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiol Sin (2016) 0.75
Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating. Med Devices (Auckl) (2016) 0.75
An Atelocollagen Coating for Efficient Local Gene Silencing by Using Small Interfering RNA. Mol Ther Nucleic Acids (2017) 0.75
Biodegradable Cable-Tie Rapamycin-eluting Stents. Sci Rep (2017) 0.75
Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials. PLoS One (2014) 0.75
Stent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature. Thromb J (2015) 0.75
A rare and serious unforeseen complication of cutting balloon angioplasty. Case Rep Cardiol (2014) 0.75
Silicone-covered biodegradable magnesium-stent insertion in the esophagus: a comparison with plastic stents. Therap Adv Gastroenterol (2016) 0.75
Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. Physiol Rep (2017) 0.75
Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis. PLoS One (2016) 0.75
Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in Humans. J Am Heart Assoc (2016) 0.75
Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications. Mol Aspects Med (2017) 0.75
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent. J Mater Sci Mater Med (2017) 0.75
Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus. Glycoconj J (2008) 0.75
Technical feasibility and tissue reaction after silicone-covered biodegradable magnesium stent insertion in the oesophagus: a primary study in vitro and in vivo. Eur Radiol (2016) 0.75
Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries. Clin Res Cardiol (2008) 0.75
HUCMNCs protect vascular endothelium and prevent ISR after endovascular interventional therapy for vascular diseases in T2DM rabbits. Mol Cell Biochem (2017) 0.75
Cu-bearing steel reduce inflammation after stent implantation. J Mater Sci Mater Med (2015) 0.75
Is there an association between flow diverter fish mouthing and delayed-type hypersensitivity to metals?-a case-control study. Neuroradiology (2017) 0.75
miR-21-mediated tumor growth. Oncogene (2006) 9.90
Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis (2000) 9.45
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A (2001) 6.99
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (2001) 6.84
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell (1998) 4.77
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation (1996) 3.58
Rebinding and relaxation in the myoglobin pocket. Biophys Chem (1987) 3.58
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem (2000) 3.26
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med (1990) 3.12
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol (2000) 2.99
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
Isolation and characterization of a new human microsporidian, Encephalitozoon hellem (n. sp.), from three AIDS patients with keratoconjunctivitis. J Infect Dis (1991) 2.95
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med (1997) 2.86
Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping. Anal Chem (2000) 2.81
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Structural basis for self-association and receptor recognition of human TRAF2. Nature (1999) 2.74
Can coronary flow parameters after stent placement predict restenosis? Cathet Cardiovasc Diagn (1995) 2.69
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation (1999) 2.67
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol (2000) 2.67
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology (2001) 2.51
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell (2001) 2.43
Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A (1997) 2.37
A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol (1995) 2.30
Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys J (1991) 2.30
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation (2000) 2.28
The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell (1999) 2.25
Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation (2001) 2.22
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol (2001) 2.22
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 2.19
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med (1993) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med (1998) 2.11
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation (2001) 2.10
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med (1997) 2.09
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation (1997) 2.05
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol (1995) 1.95
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol (1995) 1.93
Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv (2001) 1.93
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res (2001) 1.93
Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis (2010) 1.92
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol (2001) 1.86
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest (1997) 1.86
Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 1.86
Seeding of intravascular stents with genetically engineered endothelial cells. Circulation (1989) 1.82
Side-branch occlusion after rotational atherectomy of in-stent restenosis: incidence, predictors, and clinical significance. Catheter Cardiovasc Interv (2000) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci (2001) 1.76
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol (1993) 1.71
High-cooperativity coupling of electron-spin ensembles to superconducting cavities. Phys Rev Lett (2010) 1.69
Orientation of carbon monoxide and structure-function relationship in carbonmonoxymyoglobin. Proc Natl Acad Sci U S A (1988) 1.67
Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem (2001) 1.66
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation (2000) 1.65
Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.65
Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect (1994) 1.64
Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci U S A (2000) 1.64
Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol (2000) 1.64
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J (1998) 1.62
Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol (2000) 1.62
Inhomogeneous broadening in spectral bands of carbonmonoxymyoglobin. The connection between spectral and functional heterogeneity. Biophys J (1990) 1.62
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 1.61
Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer (2004) 1.61
Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation (2001) 1.61
Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation (1997) 1.61
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol (2000) 1.60
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene (2006) 1.59
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene (2010) 1.58
Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol (1994) 1.58
Morphology of single olivocerebellar axons labeled with biotinylated dextran amine in the rat. J Comp Neurol (1999) 1.57
Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A (1997) 1.57
Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A (1995) 1.56
Balloon-expandable intracoronary stents in the adult dog. Circulation (1987) 1.56
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health (2003) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Valproic acid therapy in childhood epilepsy. JAMA (1980) 1.54
Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J Virol (1999) 1.54
Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation (1993) 1.54